December 5 - 7, 2024 - Ponte Vedra Inn & Club - Ponte Vedra Beach, Florida This course offers Live (in-person) and Livestream (virtual) attendance options Mayo Clinic's 10th Annual Symposium on lmmuno-Oncology and Tumor Microenvironment Crosstalk: From Novel Therapeutics to transformative practice, brings together scientists, clinical experts and industry partners in the field of tumor microenvironment, immune therapy, anti-angiogenesis and targeted therapy. This symposium will facilitate the exchange of ideas and new scientific direction involving basic biology and pathways that eventually lead to new individualize therapy for patients. Clinician scientists will present the results of ongoing clinical trials on targeted therapy including immune therapy, anti-angiogenic therapy and others. Novel genetic and imaging methods to assess alteration of tumor microenvironment for monitoring the effectiveness of therapeutic responses in both pre-clinical and clinical trials will be discussed. Different clinical challenges and benefits of new therapeutic avenues including cardio-oncology will be presented. Overall, it is hoped that this symposium will assist in establishing strong collaborations among leading national, international, and Mayo Clinic experts in the field.

December 5, 2024 - 12:00 - 1:00 p.m. Central Time - Webinar As of November 1, 2023, civil surgeons were required to enter records of adjustment of status applicants with tuberculosis classification into the eMedical system. In this session, participants gain an understanding of the eMedical system, enabling them to navigate and comply with tuberculosis reporting requirements. The course ensures that civil surgeons are well-prepared to integrate eMedical into their workflow, promoting efficiency and accuracy in tuberculosis case management.